Michimasa Kato

1.3k citations
34 papers · 1.1k indexed · h-index 16
Topics
Retinoids in leukemia and cellular processes (10 papers)Glycosylation and Glycoproteins Research (6 papers)Blood groups and transfusion (4 papers)

In The Last Decade

Michimasa Kato

34 papers receiving 1.0k citations

Peers

Michimasa Kato
Comparison fields: 5 of 79
  • Molecular Biology 701
  • Biochemistry 179
  • Genetics 176
  • Cell Biology 138
  • Immunology 124
Replace Eisaku Yoshida with:
Eisaku Yoshida Japan
S. Basu India
Svetlana Bergelson United States
Masayoshi Kondo Japan
Shiquan Liu China
Shinzo Nishi Japan
Kageaki Kuribayashi Japan
Jinglun Xue China
Roberta Rivi United States
Peter Feick Germany
Michimasa Kato relative to Eisaku Yoshida Japan Eisaku Yoshida's profile →
Citations per field
00.5×8.1×
Eisaku Yoshida · 1×
Citations per year

Countries citing papers authored by Michimasa Kato

Since Specialization
Citations

This map shows the geographic impact of Michimasa Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michimasa Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michimasa Kato more than expected).

Fields of papers citing papers by Michimasa Kato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michimasa Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michimasa Kato. The network helps show where Michimasa Kato may publish in the future.

Co-authorship network of co-authors of Michimasa Kato

This figure shows the co-authorship network connecting the top 25 collaborators of Michimasa Kato. A scholar is included among the top collaborators of Michimasa Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michimasa Kato. Michimasa Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 44
2 3
3 7
4 12
5 7
6 16
7 8
8 5
9 4
10 8
11 19
12 18
13 10
14 32
15 45
16 48
17 184
18 17
19 27
20 32

About Michimasa Kato

Michimasa Kato is a scholar working on Hematology, Pharmacology and Microbiology, having authored 34 papers that have together received 1.1k indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (10 papers), Glycosylation and Glycoproteins Research (6 papers) and Blood groups and transfusion (4 papers). The work is most often cited by research in Biochemistry (179 citations), Hepatology (91 citations) and Molecular Biology (701 citations). Michimasa Kato has collaborated with scholars based in Japan, United States and Armenia. Frequent co-authors include DeWitt S. Goodman, William S. Blaner, D S Goodman, J.R. Mertz, Kusal K. Das, Weng Kong Sung, Masaharu Naiki, Maurice Cohen, Kaare R. Norum and Naohiro Kato. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026